This $400 Million Pot Stock Can Go to $2 Billion

Hexo Corp. (TSX:HEXO)(NYSE:HEXO) is the most undervalued pot stocks today, even though it has partnerships with multi-billion dollar firms.

| More on:

Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) is one of the most popular brands in Canada. Its market cap exceeds $10 billion, giving it plenty of liquidity to pursue long-term growth opportunities. If you look closely, it’s clear that Molson is about to send shares of one pot stock soaring.

It’s important to note that Molson hasn’t entered the marijuana industry directly. Instead, it partnered with an existing producer to co-create and c0-market cannabis-infused products. It’s a match made in heaven. Molson can focus on its core business, but still maintain exposure to skyrocketing demand for cannabis.

The marijuana company that Molson partnered with isn’t well known. In fact, this pot stock’s market cap is 95% smaller than Molson’s. That valuation should change rapidly once the first products are introduced. It’s not hard to see the market cap rising five times higher, surpassing the $2 billion mark.

This is a limited-time opportunity to buy a high-growth stock at a bargain price.

This partnership is real

In 2019, Molson partnered with Hexo Corp. (TSX:HEXO)(NYSE:HEXO) with to goal of co-launching CBD-infused beverages. Afterwards, the two companies would collaborate on THC-infused drinks. The pairing was a perfect match.

For years, Molson faced sluggish demand for big-brand beer. The market has been ceding market share to craft producers, as well as other forms of imbibing like alcoholic seltzers and marijuana. The company needed to find another growth market to tap.

Hexo, meanwhile, was never set on being just another pot stock. While the competition focused on growing production, Hexo opted to secure long-term partnerships. The business is specifically built for outside entities to co-create products. Each company only has to invest in what they do best, leaving the rest to the partner.

At the time of the deal, Hexo was worth more than $1 billion. Then the pot stock bear market of 2019 hit. Every producer was crushed. Despite its valuable partnership with Molson, Hexo shares never recovered. Today, they’re still trading near all-time lows, pegging the entire business value at just $400 million.

Bet on this pot stock?

The market has forgotten about the Molson-Hexo partnership, but you shouldn’t. This year, we got news that the joint venture is headed for big things.

“Molson Coors and Hexo have formed a joint venture to explore opportunities for non-alcohol hemp-derived CBD beverages in Colorado: part of Molson Coors’ strategy to grow beyond the beer aisle,” reports Beverage Daily.

This is an expansion to the earlier deal, which only covered Canada. As Molson grows in the U.S., it’s now clear that it will bring this pot stock along for the ride.

“Molson Coors and Hexo have already built a great partnership in Canada that we believe will produce some of the best adult non-alcohol beverage brands in the Canadian market,” noted Hexo’s CEO in a press release.

Importantly, both the U.S. and Canada ventures will launch their first products this year. It’s an opportunity that the market clearly isn’t pricing in.

If you want to bet on high-growth pot stocks, Hexo should top your list.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Coronavirus

A train passes Morant's curve in Banff National Park in the Canadian Rockies.
Coronavirus

Retirees: What Rising Inflation Means for Your CPP Payments

If you aren't getting enough CPP, you can consider investing in stocks and ETFs. Canadian National Railway (TSX:CNR) is one…

Read more »

Coronavirus

Air Canada Stock Is Starting to Get Ridiculously Oversold

Air Canada (TSX:AC) has been beaten down to absurd lows.

Read more »

Coronavirus

Should You Buy Air Canada Stock While it’s Below $18?

Air Canada (TSX:AC) stock is below $18. Should you invest?

Read more »

Illustration of data, cloud computing and microchips
Stocks for Beginners

3 Canadian Stocks That Could Still Double in 2024

These three Canadians stocks have been huge winners already in 2024, but still have room to double again in the…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Can Air Canada Stock Recover in 2024?

Air Canada (TSX:AC) stock remains close to its COVID-19 era lows, even though its business has recovered.

Read more »

A airplane sits on a runway.
Coronavirus

3 Things to Know About Air Canada Stock Before You Buy

Air Canada stock continues to hover below $20 despite the sharp rise in travel demand seen across the industry. What's…

Read more »

Stocks for Beginners

If You Invested $1,000 in WELL Health in 2019, Here is What It’s Worth Now

WELL stock (TSX:WELL) has fallen pretty dramatically from all-time highs, but what if you bought just before the rise? Should…

Read more »

Coronavirus

2 Pandemic Stocks That Are Still Rising, and 1 Offering a Major Deal

There are some pandemic stocks that crashed and burned, while others have made a massive comeback. And this one stock…

Read more »